Purple Biotech (PPBT) Total Non-Current Liabilities (2017 - 2021)

Purple Biotech (PPBT) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $842000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Total Non-Current Liabilities fell 11.65% to $842000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $842000.0, a 11.65% decrease, with the full-year FY2021 number at $842000.0, down 11.65% from a year prior.
  • Total Non-Current Liabilities was $842000.0 for Q4 2021 at Purple Biotech, down from $953000.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.5 million in Q4 2017 to a low of $313000.0 in Q4 2019.
  • A 5-year average of $807000.0 and a median of $842000.0 in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: plummeted 73.39% in 2018, then soared 204.47% in 2020.
  • Purple Biotech's Total Non-Current Liabilities stood at $1.5 million in 2017, then tumbled by 73.39% to $405000.0 in 2018, then decreased by 22.72% to $313000.0 in 2019, then skyrocketed by 204.47% to $953000.0 in 2020, then decreased by 11.65% to $842000.0 in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Total Non-Current Liabilities are $842000.0 (Q4 2021), $953000.0 (Q4 2020), and $313000.0 (Q4 2019).